Exclusive launch: preventing hereditary cancer in Jewish communities

JW3

Ovarian Cancer Action is proud to launch our new Hereditary Cancer Risk Tool. Join our exclusive drinks reception and expert panel discussion at JW3 on the 12th June to hear how our Risk Tool could save lives in the Jewish community.

Register here

Approximately 15-20% of ovarian cancer cases are caused as a result of inherited genetic mutations called BRCA 1, BRCA 2 and Lynch Syndrome. The general population has a 1 in 400 to 1 in 800 chance of having a BRCA gene mutation. In people of Akhenzani Jewish heritage, this increases to 1 in 40. Awareness of these genetic conditions in Jewish communities is low. But knowledge is power. Knowing your genetic status could save your life or that of your loved ones.

These genetic conditions can be passed down through the male or female line to next generations. Let's stop it before it takes hold. 

Join our launch event and be part of a discussion with our panel of experts:

  • Jo Stanford, Hereditary Cancer Prevention Specialist & Hereditary Cancer Risk Tool developer

  • Dr Jonathan Krell, Senior Lecturer of Gynaecological Oncology at Imperial College & Genetics Researcher at the Ovarian Cancer Action Research Centre

  • Dr Angela George, Consultant in Oncogenetics, The Royal Marsden Hospital

  • Rabbi Yoni Birnbaum LLB (Hons) MA, Rabbi of the Hadley Wood Jewish Community, lecturer on Jewish law and thought, member of the Rabbinical Council of the United Synagogue and Associate Faculty of the London School of Jewish Studies.

  • Laura Moses, Ovarian Cancer Patient Advocate

We believe that everyone has the right to know their genetic status and if necessary, be able to take action and reduce their risk of ovarian, and other cancers.

We are on a mission to fight back against a cancer that takes the life of another woman every 2 hours in the UK. We want to prevent cancer where ever possible. Knowing your genetic status could mean you we can stop cancer before it even develops.

Register here